225220 — Genolution Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for Genolution, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,951	85,303	72,834	38,085	9,761
Cost of Revenue
Gross Profit	2,596	63,252	53,396	26,353	4,521
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	3,803	31,261	31,553	23,085	17,897
Operating Profit	148	54,041	41,281	14,999	-8,136
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-287	43,281	43,533	17,239	-6,653
Provision for Income Taxes
Net Income After Taxes	-287	32,046	34,394	14,602	-5,550
Net Income Before Extraordinary Items
Net Income	-287	32,046	34,394	14,602	-5,550
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-287	32,046	34,394	14,602	-5,550
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-22.7	2,038	1,796	755	-174
Dividends per Share